CIK 0000943819
- Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980152841
- Phone
- +1 858-746-2400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- 4 Shares withheld for taxes Director gave up 7,314 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 38.21 shares (to pay taxes)
- 4 Planned sale Director sold 2,000 shares at $252.05 ($504,100)
- 4 Shares withheld for taxes Chairman and CEO gave up 7,896.57 shares (to pay taxes)
- 4 Planned sale Director sold 487 shares at $250.25 ($121,872)
- 4 Shares withheld for taxes Global General Counsel gave up 1,525.02 shares (to pay taxes)
- 4 Planned sale Chairman and CEO sold 8,011 shares at $249.75 ($2,000,773)
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $247.54 ($742,620)
- 4 Planned sale Chief Executive Officer sold 8,009 shares at $282.85 ($2,265,332)
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $274.36 ($823,080)
- 4 Planned sale Global General Counsel sold 100 shares at $274.36 ($27,436)
- 4 Planned sale Chief Executive Officer sold 8,009 shares at $278.14 ($2,227,590)
- 4 Grant or award Director acquired 241 shares (grant or award)
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $270.77 ($812,310)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Product Officer acquired 5,462 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 5,462 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 12,289 shares (grant or award)
- 4 Open-market sale Director sold 2,575 shares at $287.10 ($739,289)
- 4 Grant or award Global General Counsel acquired 2,941 shares (grant or award)
Page 4 of 92 · 1,833 filings